Because this epigenetic regulation is reversed in glucose-unresponsive islets from diabetic mice and humans, which express higher levels of Fxyd3, loss of imprinting of this locus may contribute to beta-cell dysfunction characteristic of type 2 diabetes. Here, FXYD3 is linked to type 2 diabetes mellitus.